CureVac

Description

CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA. The company's focus is on developing vaccines for infectious diseases and drugs to treat for cancer and rare diseases.  The company is also developing a vaccine for COVID-19 based on mRNA.

Career Page(s)

Company Location(s)

Frankfurt
Germany

Tübingen
Germany

250 Summer St
Boston, MA 02210
United States